Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen [Phase 4]
Phase 4 trial evaluating Veramyst for reducing nasal and ocular symptoms after early allergen exposure in allergic rhinitis. Results have be…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) [Phase 2, Phase 3]
Clinical trial update reporting efficacy and long-term safety of a ragweed sublingual immunotherapy tablet (SCH 39641) in adults with ragwee…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens [Phase 3]
Phase 3 trial update reporting safety and efficacy of aluminium hydroxide-adsorbed birch pollen allergoid immunotherapy for birch pollen all…
-
FDA approval · 2014-07-03FDA Approved: EQUALINE CONGESTION RELIEF — Original Application (United Natural Foods, Inc. dba UNFI)
FDA approved Equaline Congestion Relief, a generic combination of ibuprofen and phenylephrine hydrochloride. It is intended for temporary re…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Regulatory AVAMYS Nasal Spray PMS
This clinical trial update notes the completion of a post-marketing surveillance study for AVAMYS nasal spray (mometasone furoate) in allerg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-06-12FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) submitted by Chattem, Inc.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM [Phase 2]
Phase 2 trial assessing safety, tolerability, and immunogenicity of escalating doses of gpASIT+TM in hay fever patients.
-
FDA approval · 2014-06-03FDA Approved: HYDROXYZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for hydroxyzine hydrochloride (HYDROXYZINE HYDROCHLORIDE) from Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Biomarkers of Cockroach Sublingual Immunotherapy 2 [Phase 1, Phase 2]
Phase 1/Phase 2 trial update reporting biomarker findings from cockroach sublingual immunotherapy in asthma and perennial allergic rhinitis,…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant [Phase 2]
Phase 2 trial update assessing the safety of subcutaneously administered gpASIT+ in hay fever patients, with and without an immunoregulating…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) [Phase 2]
Phase 2 safety study of a ragweed pollen immunotherapy tablet in adults aged 50 and older (Study P06081) has completed, with results posted …
-
FDA approval · 2014-05-16FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for CHILDRENS ZYRTEC (cetirizine hydrochloride) submitted by Kenvue Brands LLC.
-
FDA approval · 2014-05-15FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin Allergy (loratadine) by Bayer HealthCare LLC. The filing relates to labeling and/or ind…
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: ToleroMune House Dust Mite Follow on Study
ToleroMune was studied in a follow-on trial for house dust mite allergy and rhinoconjunctivitis; the study status is listed as completed.
-
FDA approval · 2014-05-14FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion, a combination of fexofenadine hydrochloride and pseudoephe…
-
FDA approval · 2014-05-12FDA Approved: DESLORATADINE — Supplemental Application (Virtus Pharmaceuticals, LLC)
FDA approved a supplemental application for desloratadine from Virtus Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray
A completed clinical trial comparing Ectoin Allergy Nasal Spray with Beclomethasone nasal spray for allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis
A completed clinical trial evaluated ectoine-containing nasal spray and eye drops for allergic rhinitis/rhinoconjunctivitis; the available s…
-
FDA approval · 2014-04-23FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for CLARINEX (desloratadine) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge [Phase 2]
Pfizer conducted a Phase 2 trial evaluating a new nasal decongestant for allergic rhinitis using a nasal allergen challenge; the study compl…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: PURETHAL Birch RUSH Study [Phase 4]
Phase 4 clinical trial update for PURETHAL Birch RUSH evaluating treatment of allergic rhinitis and allergic rhinoconjunctivitis; the study …
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Probiotic Administration and Perennial Allergic Rhinitis [NA]
The clinical trial evaluating probiotic administration for perennial allergic rhinitis has completed.
-
FDA approval · 2014-04-07FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited under an ANDA.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Phase 2 Study in Adults Sensitized to Cat [Phase 2]
Phase 2 trial in adults with cat allergy has completed, and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Assessment of Fluticasone Propionate on Ocular Allergy Symptoms [Phase 3]
A Phase 3 clinical trial evaluated fluticasone propionate for ocular allergy symptoms in allergic rhinitis patients; results were posted in …